-
Luminex Corporation Launches New FDA Cleared Test
Wednesday, November 17, 2010 - 10:46am | 70Luminex Corporation (Nasdaq: LMNX), today announced that it has commercially launched its first pharmacogenetic test, the xTAG® CYP2D6 Kit, which recently received 510 clearance from the U.S. Food and Drug Administration (FDA). The new test enables a personalized medicine approach to help...
-
AIA's Architecture Billings Index (ABI) Declined 1.7 Points To 48.7, Oppenheimer Reports
Wednesday, November 17, 2010 - 8:46am | 171In a report released this morning, Oppenheimer said that relevant to its non-residential construction-related stocks under coverage – United Rentals, Inc. (NYSE: URI), RSC Holdings Inc. (NYSE: RRR), McGrath RentCorp (NASDAQ: MGRC), Essex Rental Corporation (NASDAQ: ESSX), Ritchie Bros. (NYSE: RBA...
-
Pressure BioSciences (PBIO) Reports Strong Third Quarter Financial Results - Analyst Blog
Wednesday, November 17, 2010 - 6:16am | 903Grant Zeng, CFA On November 16, 2010, Pressure BioSciences, Inc. (PBIO) reported financial results for the third quarter ended September 30, 2010. Total revenue for 3Q10 was $372,103 compared to $317,427 for the comparable period in 2009, a 17% increase. Sales from PCT products and services...
-
PerkinElmer Remains Neutral - Analyst Blog
Tuesday, November 16, 2010 - 5:33pm | 430We reaffirm our Neutral recommendation on PerkinElmer (PKI). Both revenues and earnings for third-quarter 2010 beat the Zacks Consensus Estimate. On the positive side, PerkinElmer has established itself as the market leader, particularly in genetic screening segments, and holds one of the top two...
-
Pressure BioSciences, Inc. Announces Third Quarter EPS of $.26
Tuesday, November 16, 2010 - 11:51am | 93Pressure BioSciences, Inc. (Nasdaq: PBIO) today announced continued strong financial performance for the three and nine month periods ended September 30, 2010, compared to the same periods in 2009. Total revenue for the third quarter of 2010 was $372,103 compared to $317,427 for the comparable...
-
Luminex Downgraded to Underperform - Analyst Blog
Monday, November 15, 2010 - 7:03pm | 399We downgrade our recommendation on Luminex Corporation (LMNX) to Underperform following the company's lower-than-expected third quarter results and a less favorable outlook. Third-quarter fiscal 2010 adjusted loss per share of 2 cents missed the Zacks Consensus Estimate of earnings of 4 cents....
-
RBC Capital Decreases Qiagen PT To $18
Monday, November 15, 2010 - 11:16am | 29RBC Capital announced today that it has decreased its PT of Qiagen (NASDAQ: QGEN) to $18, down from its previous PT of $20.
-
Goldman Reiterates Buy on PAREXEL International (PRXL)
Monday, November 15, 2010 - 8:29am | 124Goldman Sachs is reiterating its Buy rating on PAREXEL International Corporation (NASDAQ: PRXL) and $28 price target. In a note sent to investors, Goldman writes, "Our positive view of an attractive clinical late-stage environment was strengthened again this quarter as we saw book-to-bills ratios...
-
Charles River Misses, Trims Outlook - Analyst Blog
Friday, November 12, 2010 - 3:33pm | 517Charles River Laboratories International Inc. (CRL) posted third quarter fiscal 2010 earnings (excluding special items) of 45 cents per share, falling short of the Zacks Consensus Estimate of 49 cents and 30.8% below the year-ago earnings of 65 cents. The decrease in earnings was attributable to...
-
ERT to Present at Lazard Capital Markets' 7th Annual Healthcare Conference
Friday, November 12, 2010 - 11:45am | 64ERT (Nasdaq: ERES), announced today that Dr. Michael J. McKelvey, the Company's President and CEO, is scheduled to present at Lazard Capital Markets' 7th Annual Healthcare Conference at 10:55 AM EST on November 16, 2010 in New York City, New York. eResearchTechnology, Inc. is a global provider of...
-
Pressure Bio Wins New Grant - Analyst Blog
Friday, November 12, 2010 - 11:33am | 59This article has been unpublished. Walter, need new message. PRESSURE BIOSCI (PBIO): Free Stock Analysis Report Zacks Investment Research
-
Zacks Analyst Blog Highlights: Lions Gate Entertainment, Amylin Pharmaceuticals, Amylin Pharmaceuticals, Eli Lilly, Alkermes and Novo Nordisk - Press Releases
Friday, November 12, 2010 - 11:33am | 1948For Immediate Release Chicago, IL – November 12, 2010 – Zacks.com Analyst Blog features: Lions Gate Entertainment Corporation (LGF), Amylin Pharmaceuticals (AMLN), Eli Lilly (LLY), Alkermes, Inc. (ALKS) and Novo Nordisk (NVO). Get the most recent insight from Zacks Equity Research with the free...
-
Pressure Bio Wins New Grant - Analyst Blog
Friday, November 12, 2010 - 11:33am | 726Written by Grant Zeng, CFA. A Competitive Grant Has Been Awarded to PCT Platform Technology Earlier this month, Pressure BioSciences, Inc. ( PBIO )announced that it has been awarded a Therapeutic Discovery Grant (TDG) for $244,479. The TDG Program is designed for companies with 250 employees...
-
MEDTOX Scientific Declares Special One-Time Dividend of $1.25 Per Share
Friday, November 12, 2010 - 9:58am | 89MEDTOX Scientific, Inc. (Nasdaq: MTOX) today announced that its board of directors approved a special one-time cash dividend of $1.25 per share. The special dividend will be payable on December 1, 2010, to stockholders of record on November 22, 2010. Cash for the dividend will be provided by cash...
-
Earnings Scorecard: Thermo Fisher - Analyst Blog
Friday, November 12, 2010 - 9:30am | 1068Subsequent to the announcement of Thermo Fisher Scientific's (TMO) third quarter fiscal 2010 results on October 27, 2010, revision of estimates among analysts depict a positive trend for both fiscal 2010 and 2011. Third Quarter Highlights Thermo Fisher reported an EPS of 66 cents in the third...